Author name: TB Alliance

The 2nd Annual Stop TB Partners’ Forum, held March 24-26 in New Delhi, India, emphasized the simultaneous priorities of advancing

New Global TB Plan & WHO TB Progress Report Briefing with RESULTS Media briefing, March 23, 2004 (12:00 p.m. EST)

New Data Offer Sobering Insights Into the Significance of Drug-Resistant Tuberculosis Renowned physician, leading global TB drug-development representative to join

Statement from Christine F. Sizemore, Ph.D., and Anthony S. Fauci, M.D., National Institute of Allergy and Infectious Diseases/ National Institutes

“TB kills two million people every year, but where is the sense of urgency that will secure resources and accelerate

WHAT: Press briefing by conference call from Global TB Partners Forum in New Delhi, India to outline a new Global

Regional increases in the prevalence of multidrug resistant tuberculosis (MDR-TB) underscore the need for developing new TB treatments, as reported

Cases of tuberculosis that are resistant to most of the drugs used to treat the disease are on the rise

Doctors need a new weapon in the fight against “super strains” of tuberculosis. A survey from the World Health Organization

There may be as many as 300,000 new cases of drug-resistant tuberculosis a year in the world, and 79 percent